These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38697036)

  • 21. Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study.
    Yoo J; Jeon J; Baik M; Kim J
    Stroke Vasc Neurol; 2023 Aug; 8(4):276-283. PubMed ID: 36549762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease.
    Wang G; Zhang X; Feng M; Liu X; Guo F
    J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke.
    Jeon C; Yeon JY; Jo KI; Hong SC; Kim JS
    Stroke; 2019 May; 50(5):1130-1135. PubMed ID: 30935317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Radiological Features of Childhood Onset Adult Moyamoya Disease: Implication for Hemorrhagic Stroke.
    Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Akioka N; Kuwayama N; Kuroda S
    Neurol Med Chir (Tokyo); 2020 Jul; 60(7):360-367. PubMed ID: 32536657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Aspirin in Postoperative Management of Adult Ischemic Moyamoya Disease.
    Zhao Y; Zhang Q; Zhang D; Zhao Y
    World Neurosurg; 2017 Sep; 105():728-731. PubMed ID: 28625901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
    Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease.
    Pang CH; Cho WS; Kang HS; Kim JE
    Sci Rep; 2021 Sep; 11(1):19367. PubMed ID: 34588601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
    J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis.
    Wei W; Chen X; Yu J; Li XQ
    BMC Neurol; 2019 May; 19(1):98. PubMed ID: 31092214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis.
    Toh KZX; Koh MY; Loh EDW; Sia CH; Chong Y; Yeo LLL; Sharma VK; Lim MJR; Tan BYQ
    J Alzheimers Dis; 2024; 97(2):541-552. PubMed ID: 38108354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study).
    Onozuka D; Hagihara A; Nishimura K; Kada A; Nakagawara J; Ogasawara K; Ono J; Shiokawa Y; Aruga T; Miyachi S; Nagata I; Toyoda K; Matsuda S; Suzuki A; Kataoka H; Nakamura F; Kamitani S; Nishimura A; Kurogi R; Sayama T; Iihara K;
    BMJ Open; 2016 Mar; 6(3):e009942. PubMed ID: 27008684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
    Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
    World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset.
    Nakamura A; Takasu S; Seki Y; Saito R
    Nagoya J Med Sci; 2024 Feb; 86(1):82-90. PubMed ID: 38505724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic choice in blunt cerebrovascular injuries: Experience at a tertiary trauma center, systematic review, and meta-analysis.
    Ku JC; Priola SM; Mathieu F; Taslimi S; Pasarikovski CR; Zeiler FA; Machnowska M; Nathens A; Yang VXD; da Costa L
    J Trauma Acute Care Surg; 2021 Jul; 91(1):e1-e12. PubMed ID: 34144568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hemodynamic complexities underlying transient ischemic attacks in early-stage Moyamoya disease: an exploratory CFD study.
    Rashad S; Saqr KM; Fujimura M; Niizuma K; Tominaga T
    Sci Rep; 2020 Feb; 10(1):3700. PubMed ID: 32111936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
    Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
    Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.